The Effect of Logotherapy-Based Intervention on Depression Patients on Depression,Psychological Pain and Meaning of Life

March 21, 2025 updated by: Merve Uğuryol Ünal, Ege University

The Effect of Logotherapy-Based Intervention on Depression Patients on Depression, Psychological Pain, and Meaning of Life: Follow-Up Study With Control Group

The goal of this interventional study is to compare in logotherapy-based intervention practiced to depressed patients on depression, psychological pain and meaning of life. The main questions it aims to answer are:

  • Is the logotherapy-based intervention practiced in addition to the standard treatment in depression patients effective in reducing the depression levels of the patients?
  • Is the logotherapy-based intervention practiced in addition to the standard treatment in depression patients effective in reducing the psychological pain levels of the patients?
  • Is the logotherapy-based intervention practiced in addition to the standard treatment in depression patients effective in increasing the patients' level of meaning to life? Participants will be done online interview once a week for eight sessions. Researchers will compare intervention and control groups to see if logotherapy-based intervention practiced effect depression, psychological pain and meaning of life levels.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The research was conducted to examine the effect of logotherapy-based intervention practiced to depressed patients on depression, psychological pain and meaning of life.

The research is in a quasi-experimental research design with pre-test post-test follow-up measurement, control group. Sample selection was carried out in two stages, and in the first stage, 48 patients diagnosed with depression between September 2020 and September 2022 were referred to the researcher by the polyclinic physician. The patients were evaluated within the scope of the inclusion criteria of the study, and 32 patients with a diagnosis of depression, aged 18-65 years, voluntarily aged between 18-65, who scored 17 points or more from the Beck Depression Inventory, were accepted into the study. Patients were assigned to intervention and control groups, respectively. A total of 28 patients, 12 intervention and 16 control groups, completed the study. "Descriptive Information Form", "Beck Depression Inventory", "Psychache Scale" and "Meaning of Life Questionnaire" were used as data collection tools in the study. Online logotherapy-based intervention was administered to the individuals in the intervention group as a total of eight sessions, once a week. In order to evaluate the effect of logotherapy-based intervention, Beck Depression Inventory, Psychache Scaleand Meaning of Life Questionnaire were administered to all individuals in the sample group at time series points (pretest, posttest, follow-up test at 3rd month). In the analysis of the data, descriptive statistics, independent t-test, chi-square analysis, analysis of variance in repeated measurements, Bonferroni correction were applied.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • İzmir, Turkey
        • Ege University Faculty of Nursing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Be between the ages of 18-65
  • Having been diagnosed with depression
  • A score of 17 or higher on the Beck Depression Inventory
  • Willingness and willingness to participate in the research
  • Completed at least six interviews

Exclusion Criteria:

  • Having an active risk of suicide
  • Having psychotic symptoms
  • Having a psychiatric comorbidity
  • Using antipsychotic medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Beck Depression Inventory, Psychache Scale, Meaning of Life Questionnaire was applied to intervention group as a pre-test. Inaddition to the Standard treatment, the intervention group received a logotherapy-based intervention. Beck Depression Inventory, Psychache Scale, Meaning of Life Questionnaire was applied to intervention group as a post test and follow up test.
Behavioral: logotherapy-based intervention
Logotherapy-based intervention was administered to the individuals in the intervention group as a total of eight sessions, once a week.
No Intervention: Control group
Beck Depression Inventory, Psychache Scale, Meaning of Life Questionnaire was applied to control group as a pre-test. The control group received only standard treatment. Beck Depression Inventory, Psychache Scale, Meaning of Life Questionnaire was applied to control group as a post test and follow up test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
"Beck Depression Inventory" Scores
Time Frame: post-test (after 8 weeks) and follow-up test (after 3 months)
Beck Depression Inventory (BDI) The inventory measures depression level.The inventory assesses physical, emotional, cognitive and motivational components. The four-point Likert-type scale comprises of 21 questions. The scale has a minimum score of 0 and a maximum score of 63. As the total score increases, the depression level also increases. The scale score graded depression into four levels: normal (0-9 points), mild (10-16 points), moderate (17-29 points) and severe (30-63 points).
post-test (after 8 weeks) and follow-up test (after 3 months)
"Psychache Scale" Scores
Time Frame: post-test (after 8 weeks) and follow-up test (after 3 months)
Psychache Scale was developed to assess psychological pain. The five-point Likert-type scale consists of 13 questions. The scale has a minimum score of 13 and a maximum score of 65. As the total score increases, the psychache level increases.
post-test (after 8 weeks) and follow-up test (after 3 months)
"Meaning of Life Questionnaire" Scores
Time Frame: post-test (after 8 weeks) and follow-up test (after 3 months)
Meaning of Life Questionnaire measures the level of meaning that individuals give to life.This seven-point Likert-type scale consists of 10 questions.The scale has a minimum score of 10 and a maximum score of 70. The scale has two subscales. These subscales include the existing meaning in life (5 questions) and the search for meaning in life (5 questions).The total score is obtained by summing the subscale scores. As the total score of the scale increases, individuals' level of meaning in life increases.
post-test (after 8 weeks) and follow-up test (after 3 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ege University

Investigators

  • Study Chair: Esra ENGİN, Ege University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 4, 2020

Primary Completion (Actual)

February 4, 2021

Study Completion (Actual)

September 4, 2022

Study Registration Dates

First Submitted

January 8, 2023

First Submitted That Met QC Criteria

January 18, 2023

First Posted (Actual)

January 27, 2023

Study Record Updates

Last Update Posted (Actual)

April 8, 2025

Last Update Submitted That Met QC Criteria

March 21, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20-3T/42 (Other Identifier: Ege University Medical Research Ethics Committee)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on logotherapy-based intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe